OROS hydromorphone

DRUG4 trials

Sponsors

Mallinckrodt, Janssen Korea, Ltd., Korea

Conditions

Cancer PainChronic Low Back PainChronic PainPain

Phase 3

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

CompletedNCT00549042

MallinckrodtChronic Low Back Pain

Start: 2007-10-31End: 2009-01-31Updated: 2020-06-17

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

CompletedNCT00631319

MallinckrodtChronic Pain

Start: 2008-02-29End: 2009-06-30Updated: 2020-09-16

Phase 4

Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients

CompletedNCT01621100

Janssen Korea, Ltd., KoreaCancer Pain

Start: 2011-12-31End: 2012-09-30Updated: 2013-09-06

Unknown Phase

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

CompletedNCT01273454

Janssen Korea, Ltd., KoreaPain

Start: 2009-06-30End: 2009-12-31Updated: 2013-09-04

Related Papers

Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain.

2010-06-0159 citations